Cimcef S 250mg/125mg Injection
Marketer
Veewin Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cimcef S 250mg/125mg Injection
Cefixime and Sulbactam injection (250mg/125mg), a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and spread. Administration must be under a physician's guidance; strictly adhere to the prescribed schedule. Complete the full course, even with symptom improvement; premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and dyspepsia are potential side effects; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals require prior physician consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and sufficient hydration promote faster recovery. Your doctor may order lab tests to monitor the medication's impact.
Primary Ingredients of Cimcef S 250mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Cimcef S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cimcef S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cimcef S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cimcef S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cimcef S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Cimcef S 250mg/125mg Injection, offer a dual antibiotic approach. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. The addition of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Cimcef S 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Cimcef S (250mg/125mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nonetheless, clinical data in humans are scarce.
Breast feedingCAUTION
Administering Cimcef S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Cimcef S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cimcef S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Patients with severe hepatic impairment should receive Cimcef S 250mg/125mg Injection cautiously, with potential dose modification. For those with mild to moderate liver disease, dose adjustment is not advised. Physician consultation is recommended.
What if you forget to take Cimcef S 250mg/125mg Injection :
Omit doses of Cimcef S 250mg/125mg Injection only after discussing this with your physician.
Facts to Know About Cimcef S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently